Literature DB >> 10697063

Incidence of cervical squamous intraepithelial lesions in HIV-infected women.

T V Ellerbrock1, M A Chiasson, T J Bush, X W Sun, D Sawo, K Brudney, T C Wright.   

Abstract

CONTEXT: Women infected with human immunodeficiency virus (HIV) are at increased risk for cervical squamous intraepithelial lesions (SILs), the precursors to invasive cervical cancer. However, little is known about the causes of this association.
OBJECTIVES: To compare the incidence of SILs in HIV-infected vs uninfected women and to determine the role of risk factors in the pathogenesis of such lesions.
DESIGN: Prospective cohort study conducted from October 1,1991, to June 30, 1996.
SETTING: Urban clinics for sexually transmitted diseases, HIV infection, and methadone maintenance. PARTICIPANTS: A total of 328 HIV-infected and 325 uninfected women with no evidence of SILs by Papanicolaou test or colposcopy at study entry. MAIN OUTCOME MEASURE: Incident SILs confirmed by biopsy, compared by HIV status and risk factors.
RESULTS: During about 30 months of follow-up, 67 (20%) HIV-infected and 16 (5%) uninfected women developed a SIL (incidence of 8.3 and 1.8 cases per 100 person-years in sociodemographically similar infected and uninfected women, respectively [P<.001]). Of incident SILs, 91% were low grade in HIV-infected women vs 75% in uninfected women. No invasive cervical cancers were identified. By multivariate analysis, significant risk factors for incident SILs were HIV infection (relative risk [RR], 3.2; 95% confidence interval [CI], 1.7-6.1), transient human papillomavirus (HPV) DNA detection (RR, 5.5; 95% CI, 1.4-21.9), persistent HPV DNA types other than 16 or 18 (RR, 7.6; 95% CI, 1.9-30.3), persistent HPV DNA types 16 and 18 (RR, 11.6; 95% CI, 2.7-50.7), and younger age (<37.5 years; RR, 2.1; 95% CI, 1.3-3.4).
CONCLUSIONS: In our study, 1 in 5 HIV-infected women with no evidence of cervical disease developed biopsy-confirmed SILs within 3 years, highlighting the importance of cervical cancer screening programs in this population.

Entities:  

Mesh:

Year:  2000        PMID: 10697063     DOI: 10.1001/jama.283.8.1031

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  113 in total

1.  Anal human papillomavirus (HPV) prevalences and factors associated with abnormal anal cytology in HIV-infected women in an urban cohort from Rio de Janeiro, Brazil.

Authors:  Mary C Cambou; Paula M Luz; Jordan E Lake; José Eduardo Levi; José Ricardo Coutinho; Angela de Andrade; Thais Heinke; Mônica Derrico; Valdilea G Veloso; Ruth K Friedman; Beatriz Grinsztejn
Journal:  AIDS Patient Care STDS       Date:  2015-01       Impact factor: 5.078

2.  Factors associated with time to colposcopy after abnormal Pap testing in HIV-infected women.

Authors:  Amy S Baranoski; Elizabeth A Stier
Journal:  J Womens Health (Larchmt)       Date:  2011-12-05       Impact factor: 2.681

3.  Comparison of conventional cervical cytology versus visual inspection with acetic acid among human immunodeficiency virus-infected women in Western Kenya.

Authors:  Hillary Mabeya; Kareem Khozaim; Tao Liu; Omenge Orango; David Chumba; Latha Pisharodi; Jane Carter; Susan Cu-Uvin
Journal:  J Low Genit Tract Dis       Date:  2012-04       Impact factor: 1.925

4.  Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal "pap-test equivalent" in high-risk populations.

Authors:  Carole Fakhry; Barbara T Rosenthal; Douglas P Clark; Maura L Gillison
Journal:  Cancer Prev Res (Phila)       Date:  2011-08-11

5.  Progression and regression of premalignant cervical lesions in HIV-infected women from Soweto: a prospective cohort.

Authors:  Tanvier Omar; Sheree Schwartz; Colleen Hanrahan; Tebogo Modisenyane; Nkeko Tshabangu; Jonathan E Golub; James A McIntyre; Glenda E Gray; Lerato Mohapi; Neil A Martinson
Journal:  AIDS       Date:  2011-01-02       Impact factor: 4.177

6.  Low Papanicolaou smear screening rate of women with HIV infection: a nationwide population-based study in Taiwan, 2000-2010.

Authors:  Yen-Chin Chen; Hsiao-Ying Liu; Chung-Yi Li; Nan-Yao Lee; Wen-Chien Ko; Cheng-Yang Chou; Tung-Han Hsieh; Nai-Ying Ko
Journal:  J Womens Health (Larchmt)       Date:  2013-08-30       Impact factor: 2.681

Review 7.  Cervical cancer screening.

Authors:  Dorothy J Wiley; Bradley J Monk; Emmanuel Masongsong; Kristina Morgan
Journal:  Curr Oncol Rep       Date:  2004-11       Impact factor: 5.075

Review 8.  Incidence and progression of cervical lesions in women with HIV: a systematic global review.

Authors:  Sheri A Denslow; Anne F Rositch; Cynthia Firnhaber; Jie Ting; Jennifer S Smith
Journal:  Int J STD AIDS       Date:  2013-08-29       Impact factor: 1.359

Review 9.  Gynecologic issues in the HIV-infected woman.

Authors:  Helen E Cejtin
Journal:  Infect Dis Clin North Am       Date:  2008-12       Impact factor: 5.982

10.  Human papillomavirus prevalence and genotype distribution among HIV-infected women in Korea.

Authors:  Eun Kyoung Park; Heerim Cho; Sun Hee Lee; Seung Geun Lee; Sang Yeup Lee; Ki Hyung Kim; Chang Hun Lee; Joo Seop Chung; Ihm Soo Kwak
Journal:  J Korean Med Sci       Date:  2013-12-26       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.